2 Followers USX:PMD - Psychemedics Corp. (USD 5.445) Psychemedics Corp.
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist

Yahoo Finance

USD 5.445    -0.035 (-0.64%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

9 Apr 2020


9 Apr 2020

Day Change: -0.035 (-0.64%)

52 Wk Range: 4.54 - 14.61

Day's Range: 5.43 - 5.5

Last Volume: 35,461

Current Yield: 13.22%

Projected Yield: 13.22%

Open: USD 5.5

9 Apr 2020

Metric PMD S.Median
Beta 0.56 0.84
VaR 28.26 25.23
E.Shortfall 50.15 45.03
Liquidity 20.12K 95.2K


9 Apr 2020

PE: 10.173

Market Cap: 30M

Price Over Book: 1.667

Price Over Sales: 0.77

Return On Assets: 11%

Return On Equity: 16.4%

Price Over NAV: [Friends Only]


CEO: Raymond C. Kubacki

Headquarters: ACTON

Employees: 250

Sector: Health Technology

Industry: Medical Specialties

Useful Links


Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company's tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, and opiates, including heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine. The company offers its services to employers for applicant and employee testing; treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use; and Fortune 500 companies and small to mid-size corporations. Psychemedics Corporation was founded in 1985 and is headquartered in Acton, Massachusetts.